SCHEMBL24718823

SCHEMBL24718823

Cc1ccc(O)c(C(=O)N[C@@H]2CC(=O)N(Cc3ccc(C(F)(F)F)cc3)C2)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 2/20 0.45
▸ TMPRSS4 Q9NRS4 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ RIPK1 Q13546 1/20 0.41
▸ CCR2 P41597 2/20 0.41
▸ DRD4 P21917 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ DPP4 P27487 1/20 0.40
▸ SCN9A Q15858 1/20 0.40
▸ SCN10A Q9Y5Y9 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ P2RY14 Q15391 1/20 0.39
▸ P2RX4 Q99571 1/20 0.38
▸ P2RX7 Q99572 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718430 1.00 P2RX1 (0.45) P2RX1TMPRSS4SMN1; SMN2RIPK1CCR2
SCHEMBL24719112 0.85 SMN1; SMN2 (0.44) SMN1; SMN2MEN1ALDH1A1GAAKMT2A
SCHEMBL24718657 0.85 SMN1; SMN2 (0.44) SMN1; SMN2MEN1ALDH1A1GAAKMT2A
SCHEMBL24719133 0.85 SMN1; SMN2 (0.44) SMN1; SMN2MEN1ALDH1A1GAAKMT2A
SCHEMBL24718303 0.83 TEAD1 (0.52) DRD4MEN1ALDH1A1GAAKMT2A
SCHEMBL24718648 0.83 TEAD1 (0.52) DRD4MEN1ALDH1A1GAAKMT2A
SCHEMBL24718257 0.83 TEAD1 (0.52) DRD4MEN1ALDH1A1GAAKMT2A
SCHEMBL24718415 0.83 TP53 (0.49) P2RX1TMPRSS4RIPK1MEN1ALDH1A1
SCHEMBL24718822 0.81 P2RX1 (0.45) P2RX1TMPRSS4CCR2DRD4ALDH1A1
SCHEMBL24718283 0.80 MEN1 (0.45) SMN1; SMN2DRD4MEN1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 P2RX1 4064/4885TMPRSS4 3201/4885SMN1; SMN2 3120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback